We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWR
1476
DELISTED
SunPower Corporation Common Stock
SPWR
$3.76M ﹤0.01%
271,737
-2,980
-1% -$46.7K
AWI icon
1477
Armstrong World Industries
AWI
$7.84B
$3.75M ﹤0.01%
52,703
+2,168
+4% +$162K
MODV
1478
DELISTED
ModivCare
MODV
$3.71M ﹤0.01%
44,092
+2,484
+6% +$239K
BBT
1479
Beacon Financial Corp
BBT
$2.66B
$3.7M ﹤0.01%
147,720
+4,473
+3% +$128K
STC icon
1480
Stewart Information Services
STC
$2.08B
$3.7M ﹤0.01%
91,671
+4,552
+5% +$199K
RPD icon
1481
Rapid7
RPD
$773M
$3.68M ﹤0.01%
80,172
+340
+0.4% +$14.5K
ATRI
1482
DELISTED
Atrion Corp
ATRI
$3.68M ﹤0.01%
5,863
-32
-0.5% -$20.4K
RETA
1483
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.67M ﹤0.01%
40,408
+1,456
+4% +$85.4K
SKYW icon
1484
Skywest
SKYW
$4.34B
$3.67M ﹤0.01%
165,656
+7,274
+5% +$142K
EIG icon
1485
Employers Holdings
EIG
$889M
$3.67M ﹤0.01%
87,989
+4,845
+6% +$207K
BGS icon
1486
B&G Foods
BGS
$286M
$3.67M ﹤0.01%
236,001
+10,022
+4% +$140K
PDFS icon
1487
PDF Solutions
PDFS
$2.07B
$3.66M ﹤0.01%
86,266
+5,229
+6% +$183K
BPMC
1488
DELISTED
Blueprint Medicines
BPMC
$3.65M ﹤0.01%
81,233
+226
+0.3% +$10.2K
WNC icon
1489
Wabash National
WNC
$527M
$3.65M ﹤0.01%
148,562
+7,131
+5% +$185K
DOCN icon
1490
DigitalOcean
DOCN
$14.6B
$3.65M ﹤0.01%
93,189
-1,628
-2% -$51.2K
AXNX
1491
DELISTED
Axonics, Inc. Common Stock
AXNX
$3.64M ﹤0.01%
66,728
+1,273
+2% +$74.4K
OFG icon
1492
OFG Bancorp
OFG
$2.21B
$3.63M ﹤0.01%
145,642
+6,942
+5% +$194K
AZZ icon
1493
AZZ Inc
AZZ
$4.54B
$3.63M ﹤0.01%
88,029
+4,391
+5% +$180K
PTON icon
1494
Peloton Interactive
PTON
$2.49B
$3.62M ﹤0.01%
319,555
-5,261
-2% -$63.3K
MATW icon
1495
Matthews International
MATW
$739M
$3.62M ﹤0.01%
100,460
+3,851
+4% +$142K
VRNT
1496
DELISTED
Verint Systems
VRNT
$3.62M ﹤0.01%
97,281
+2,394
+3% +$89.3K
ZWS icon
1497
Zurn Elkay Water Solutions
ZWS
$8.53B
$3.62M ﹤0.01%
169,576
+1,050
+0.6% +$23.1K
ACH
1498
Accendra Health
ACH
$214M
$3.62M ﹤0.01%
248,533
+10,031
+4% +$180K
DGII icon
1499
Digi International
DGII
$3.1B
$3.61M ﹤0.01%
107,302
+6,617
+7% +$226K
CFLT
1500
DELISTED
Confluent
CFLT
$3.61M ﹤0.01%
149,820
+11,504
+8% +$267K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.